Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine

NCT05067894 ·Status: COMPLETED ·Phase: PHASE1

A Study of Ad26.COV2.S in Healthy Adults (COVID-19)

NCT04894305 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults

NCT04588480 ·Status: COMPLETED ·Phase: PHASE4

A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults

NCT04614948 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

NCT05313035 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine

NCT04944381 ·Status: UNKNOWN ·Phase: NA

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults

NCT05011526 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

NCT04674189 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

NCT04449276 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

NCT05188469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

NCT04545749 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

NCT05043285 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

NCT05043311 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of Ad26.COV2.S in Adults (COVID-19)

NCT04509947 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19

NCT04934111 ·Status: UNKNOWN ·Phase: PHASE1

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

NCT05012943 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

NCT05079217 ·Status: UNKNOWN ·Phase: PHASE4

UNAIR Inactivated COVID-19 Vaccine

NCT05226429 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

NCT04412538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults

NCT05171946 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

NCT04813796 ·Status: COMPLETED ·Phase: PHASE1

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

NCT04824638 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

NCT04860297 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents

NCT04535453 ·Status: COMPLETED ·Phase: PHASE2